CARLSBAD, Calif. (AP) _ GenMark Diagnostics Inc. (GNMK) on Tuesday reported a loss of $12.7 million in its fourth quarter.
The Carlsbad, California-based company said it had a loss of 27 cents per share.
The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 27 cents per share.
The molecular diagnostics company posted revenue of $14.9 million in the period.
For the year, the company reported that its loss widened to $50.6 million, or $1.15 per share. Revenue was reported as $49.3 million.
GenMark Diagnostics expects full-year revenue in the range of $65 million to $70 million.
GenMark Diagnostics shares have fallen 7.5 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $11.32, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GNMK at https://www.zacks.com/ap/GNMK
Keywords: GenMark Diagnostics, Earnings Report